Several redundant mechanisms limit immune recognition of tumours in patients with advanced BTC.46 This report explored the unique contribution of the cytokines IL-6 and GM-CSF and their relationship to signalling and myeloid cells in the context of BTC. The gene discussed is CSF2; the disease is neoplasm.